Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone in Threatened Abortion
NCT03930212Phase 4Completed
- Sponsor
- Tanta University
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of progesterone in threatened abortion (2 arms), sponsored by Tanta University. Primary endpoints: Relief of pain at 3 weeks, Completion of pregnancy beyond 20 weeks at 12 weeks and 1 more. Started Jan 2018; status: completed.
02
Drugs
progesterone
03
Conditions
threatened abortion
Beyond the preview
Go deeper on NCT03930212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03930212.